228 related articles for article (PubMed ID: 29764229)
1. Use of MPH hemostatic powder for electrophysiology device implantation reduces postoperative rates of pocket hematoma and infection.
Reynbakh O; Akhrass P; Souvaliotis N; Pamidimukala CK; Nahar H; Bastawrose J; Boktor P; Aziz JE; Mehta D; Aziz EF
Curr Med Res Opin; 2018 Oct; 34(10):1861-1867. PubMed ID: 29764229
[TBL] [Abstract][Full Text] [Related]
2. Pocket related complications following cardiac electronic device implantation in patients receiving anticoagulation and/or dual antiplatelet therapy: prospective evaluation of different preventive strategies.
Awada H; Geller JC; Brunelli M; Ohlow MA
J Interv Card Electrophysiol; 2019 Apr; 54(3):247-255. PubMed ID: 30460588
[TBL] [Abstract][Full Text] [Related]
3. Device implantation for patients on antiplatelets and anticoagulants: Use of suction drain.
Mukherjee SS; Saggu D; Chennapragada S; Yalagudri S; Nair SG; CalamburNarasimhan
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S389-S393. PubMed ID: 30595295
[TBL] [Abstract][Full Text] [Related]
4. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.
Tarakji KG; Korantzopoulos P; Philippon F; Biffi M; Mittal S; Poole JE; Kennergren C; Lexcen DR; Lande JD; Seshadri S; Wilkoff BL
Heart Rhythm; 2021 Dec; 18(12):2080-2086. PubMed ID: 34280568
[TBL] [Abstract][Full Text] [Related]
5. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
Beton O; Saricam E; Kaya H; Yucel H; Dogdu O; Turgut OO; Berkan O; Tandogan I; Yilmaz MB
BMC Cardiovasc Disord; 2016 Apr; 16():73. PubMed ID: 27105588
[TBL] [Abstract][Full Text] [Related]
6. Local gentamicin-collagen sponge reduces cardiovascular implantable electronic device infections and pocket hematoma.
Monaco C; Barone L; Cammalleri V; Stifano G; Magliano G; Geuna F; Romeo F; Sergi D
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5218-5224. PubMed ID: 35916820
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of pocket-related complications following heart rhythm device implantation. D-Stat Hemostat™ versus vacuum drainage].
Ohlow MA; Buchter B; Brunelli M; Lauer B; Schreiber M; Geller JC
Herzschrittmacherther Elektrophysiol; 2015 Mar; 26(1):45-51. PubMed ID: 25644275
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
9. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
[TBL] [Abstract][Full Text] [Related]
10. IMpact of pocKet rEvision on the rate of InfecTion and other CompLications in patients rEquiring pocket mAnipulation for generator replacement and/or lead replacement or revisioN (MAKE IT CLEAN): A prospective randomized study.
Lakkireddy D; Pillarisetti J; Atkins D; Biria M; Reddy M; Murray C; Bommana S; Shanberg D; Adabala N; Pimentel R; Dendi R; Emert M; Vacek J; Dawn B; Berenbom L
Heart Rhythm; 2015 May; 12(5):950-6. PubMed ID: 25625720
[TBL] [Abstract][Full Text] [Related]
11. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
12. Current strategies to minimize postoperative hematoma formation in patients undergoing cardiac implantable electronic device implantation: A review.
Mehta NK; Doerr K; Skipper A; Rojas-Pena E; Dixon S; Haines DE
Heart Rhythm; 2021 Apr; 18(4):641-650. PubMed ID: 33242669
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
[TBL] [Abstract][Full Text] [Related]
14. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
[TBL] [Abstract][Full Text] [Related]
15. The role of prophylaxis topical antibiotics in cardiac device implantation.
Khalighi K; Aung TT; Elmi F
Pacing Clin Electrophysiol; 2014 Mar; 37(3):304-11. PubMed ID: 24164587
[TBL] [Abstract][Full Text] [Related]
16. Management of bacteremia in patients living with cardiovascular implantable electronic devices.
DeSimone DC; Sohail MR
Heart Rhythm; 2016 Nov; 13(11):2247-2252. PubMed ID: 27546815
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association.
Traykov V; Bongiorni MG; Boriani G; Burri H; Costa R; Dagres N; Deharo JC; Epstein LM; Erba PA; Snygg-Martin U; Nielsen JC; Poole JE; Saghy L; Starck C; Strathmore N; Blomström-Lundqvist C
Europace; 2019 Aug; 21(8):1270-1279. PubMed ID: 31209483
[TBL] [Abstract][Full Text] [Related]
18. Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).
Turagam MK; Nagarajan DV; Bartus K; Makkar A; Swarup V
J Interv Card Electrophysiol; 2017 Aug; 49(2):197-204. PubMed ID: 28413854
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.
Irfan G; Czapla J; Saitoh Y; Ciconte G; Mugnai G; Conte G; Hunuk B; Velagic V; Stroker E; Chierchia GB; Nijs J; La Meir M; Wellens F; Brugada P; De Asmundis C
Europace; 2017 Jan; 19(1):81-87. PubMed ID: 26893495
[TBL] [Abstract][Full Text] [Related]
20. Bundled skin antiseptic preparation for complex cardiac implantable electronic device infection: a propensity-score matching cohort study.
Chen HC; Lee WC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC
J Hosp Infect; 2019 Nov; 103(3):311-320. PubMed ID: 31449919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
